Date published: 2025-12-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC011487 Activators

BC011487 Activators encompass a collection of chemical compounds that enhance the functional activity of BC011487 through various signaling pathways and cellular processes. Compounds such as Forskolin and Isoproterenol, by increasing intracellular cAMP levels, lead to the activation of protein kinase A (PKA) which can phosphorylate and thus enhance the activity of BC011487. Similarly, Sildenafil citrate, by preventing the degradation of cAMP and cGMP, may also activate pathways involving PKA and PKG that phosphorylate and activate BC011487. PMA, acting as a PKC activator, and Epigallocatechin gallate (EGCG), as a kinase inhibitor, alter signaling dynamics to indirectly promote the activation of BC011487. Ionomycin and A23187, through their roles in increasing intracellular calcium, can activate calcium-dependent kinases that could phosphorylate BC011487, thereby enhancing its activity. Thapsigargin also increases cytosolic calcium levels, potentially leading to the activation of BC011487 through similar calcium-dependent mechanisms.

Inhibition of specific kinases and phosphatases also plays a crucial role in the activation of BC011487. LY294002, as a PI3K inhibitor, and U0126, as a MEK1/2 inhibitor, modulate downstream signaling pathways that could favor the activation of BC011487. SB203580, through the inhibitionof p38 MAPK, alters the signaling landscape to support pathways that activate BC011487. Genistein's role as a tyrosine kinase inhibitor may reduce competitive signaling, allowing BC011487-associated pathways to become more prominent. Collectively, these chemical activators, by influencing distinct signaling pathways, ensure the robust activation of BC011487. Their actions are critical in modulating the functional landscape in which BC011487 operates, enhancing its activity without directly increasing its expression levels or requiring a direct interaction with the protein. This multifaceted approach to activation allows BC011487 to participate more effectively in its associated cellular processes, underscoring the intricate network of signaling events that converge to regulate its activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin increases intracellular calcium levels, potentially activating calcium-dependent kinases that can phosphorylate and activate BC011487.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG inhibits several protein kinases, possibly reducing competitive signaling and allowing for the preferential activation of BC011487-related pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PI3K, potentially altering downstream AKT signaling and leading to the activation of BC011487 through indirect mechanisms.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 inhibits MEK1/2, which may shift signaling dynamics in favor of pathways leading to BC011487 activation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 inhibits p38 MAPK, potentially enhancing signaling pathways that activate BC011487.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 is a calcium ionophore that increases intracellular calcium, potentially activating BC011487 through calcium-dependent pathways.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), increasing cytosolic calcium levels, which could activate BC011487.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein inhibits tyrosine kinases, which may reduce competition and enhance pathways in which BC011487 is involved.